Does 10x Genomics (TXG) Have a Strong Growth Opportunity Ahead?
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” first quarter 2024 investor letter.
10X Genomics Inc. (TXG)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 6,283,812 | $235,831,466 | +56% | 1.63% |
| 2. | Generation Investment Management David Blood And Al Gore | 1,414,124 | $53,072,074 | -8% | 0.24% |
| 3. | Millennium Management Israel Englander | 1,132,428 | $42,500,023 | +312% | 0.01% |
| 4. | Freshford Capital Management Michael Doheny | 783,238 | $29,394,922 | +157% | 4.37% |
| 5. | Alyeska Investment Group Anand Parekh | 706,492 | $26,514,645 | -1% | 0.16% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $40.49 | 158 | Officer | 60,046 | 2022-05-13 | Filing | |
| $40.49 | 158 | Officer | 97,523 | 2022-05-13 | Filing | |
| $39.00 | 300,000 | Director | 300,000 | 2019-09-16 | Filing | |
| $39.00 | 300,000 | Director | 300,000 | 2019-09-16 | Filing | |
| $39.00 | 187,500 | Large Shareholder | 187,500 | 2019-09-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.30 | 2,936 | 146,203 | 2024-05-22 | Filing | ||
| $24.30 | 4,877 | 889,641 | 2024-05-22 | Filing | ||
| $24.30 | 4,087 | 350,055 | 2024-05-22 | Filing | ||
| $44.00 | 4,660 | 842,900 | 2024-03-04 | Filing | ||
| $46.34 | 2,821 | 847,560 | 2024-02-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,785,536 | $715,478,620 | 0.05% | |
| 2. | 9,011,332 | $504,274,139 | 0.01% | |
| 3. | 7,919,976 | $443,201,856 | 0.36% | |
| 4. | 5,705,392 | $319,273,759 | 0% | |
| 5. | 4,179,415 | $233,880,121 | 0.02% |
News See All
10x Genomics, Inc. (NASDAQ:TXG) Q1 2024 Earnings Call Transcript
Operator: Good day everyone and welcome to the 10x Genomics First Quarter 2024 Earnings Call. Today's call is being recorded.
11 Oversold MidCap Stocks To Buy Now
In this piece, we will take a look at the 11 oversold midcap stocks to buy now.
11 Oversold Healthcare Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold healthcare stocks to buy right now.
10x Genomics, Inc. (NASDAQ:TXG) Q4 2023 Earnings Call Transcript
10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.41 EPS, expectations were $-0.36. 10x Genomics, Inc.
12 Best Genomics Stocks To Buy Now
In this piece, we will take a look at the 12 best genomics stocks to buy now.
Harvard University Stocks List: Top 12 Picks
In this piece, we will take a look at Harvard University stocks list: top 12 picks.
Here’s Why You Should Invest in 10x Genomics (TXG)
Baron Funds, an investment management company, released its “Baron Discovery Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
10x Genomics, Inc. (NASDAQ:TXG) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. My name is Aaron, and I will be your conference operator for today.
Top 5 Genomics Companies in the World
10x Genomics, Inc. (NASDAQ:TXG) is a backend genomics company that provides products that help with gene mapping.
Billionaire Hedge Funds
